Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 28, 2021ScienceOpen Access

MAIT cell activation augments adenovirus vector vaccine immunogenicity

View Full Paper
Ask AI
Bookmark
Share

Authors

NPNicholas M. ProvineAAAli AminiLGLucy C. Garner

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Provine et al. (2021) studied this question.

synapsesocial.com/papers/6a759e6127eb2deb12e8c41dhttps://doi.org/10.1126/science.aax8819
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial2020 · 2,634 citations
  2. 2MAIT Cells in Health and Disease2020 · 215 citations
  3. 3Novel epoxysuccinyl peptides Selective inhibitors of cathepsin B, in vitro1991 · 274 citations
  4. 4Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens2013 · 198 citations
  5. 5Fast gene set enrichment analysis2016 · 3,782 citations